LHC Group Inc
NASDAQ:LHCG
LHC Group Inc
NASDAQ:LHCG
Price:
169.81 USD
Market Closed
Updated:
May 2, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of LHCG.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LHCG
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
LHCG Competitors Multiples
LHC Group Inc Competitors
LHC Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
LHC Group Inc
NASDAQ:LHCG
|
5.2B USD | 2.3 | 82.4 | 35.8 | 41.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
104.5B USD | 0.5 | 20.2 | 10.4 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 0.5 | 20 | 10.3 | 13.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
72.5B USD | 0.2 | 8.7 | 7.9 | 7.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 1.2 | 45.6 | 10.6 | 25.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 1.6 | 18.1 | 10.8 | 14.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 23.3 | 6.9 | 16.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.4B USD | 1 | 18 | 8.6 | 12.7 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
